All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Organs must be appropriately sized and patterned to function properly and meet physiological needs of adult animals. To achieve proper organ size and function, a multitude of different cell types are produced over time and in space. Yet, it remains unclear how different cell types with different molecular programs integrate their own growth with that of their nearby neighbors, some of which have different developmental origins. This is particularly true for stem cells, many of which reside within specialized microenvironments composed of many different cell types. Hormones and other secreted growth factors and cytokines have clear and important roles in growth regulation from the single-cell to tissue level and beyond \[[@pbio.3000721.ref001]--[@pbio.3000721.ref006]\]. What is less understood is whether local growth decisions are coordinated in response to nutrient availability, what regulatory networks coordinate local growth, and whether coordinated growth is required for tissue function. Dietary nutrients also play important roles in growth regulation because they provide the building blocks for biosynthesis of macromolecules (lipids, proteins, and nucleic acids) and serve as cofactors used in metabolic reactions.

Here, we investigate how growth occurs in the *Drosophila* brain in response to dietary nutrients during development. In *Drosophila*, nutrient-sensing pathways, including insulin/phosphoinositide 3-kinase (PI3-kinase) and target of rapamycin (TOR)-kinase, are evolutionarily conserved, and genetic tools for cell-type--specific manipulation of gene function are available \[[@pbio.3000721.ref007]--[@pbio.3000721.ref009]\]. The *Drosophila* brain is well-suited for investigating how growth is regulated and coordinated among different cell types in response to dietary nutrients because it contains a multitude of different cell types, including a heterogeneous population of neural stem cells and progenitors, a diverse array of specialized glia, different neuron subtypes including neurosecretory neurons, and a tracheal network of branched epithelial tubules for oxygen exchange. Furthermore, in *Drosophila*, the time when animals receive their first dietary nutrients can be precisely controlled and the growth of molecularly and functionally distinct cell types assayed over time using available markers. Better understanding of how dietary nutrients regulate brain growth and development is fundamentally important given the incidence of human neurodevelopmental disorders and defects associated with poor nutrient quality and/or limited nutrient availability \[[@pbio.3000721.ref010]--[@pbio.3000721.ref014]\].

*Drosophila* receive their first dietary nutrients after consuming their first meal as freshly hatched larvae, which occurs about 22 hours (at 25°C) after fertilization following completion of embryogenesis. Dietary amino acids stimulate TOR-kinase pathway activity in the fat body, a lipid storage organ with endocrine function similar to the mammalian liver \[[@pbio.3000721.ref015],[@pbio.3000721.ref016]\]. In response to dietary nutrients, fat-body--derived signals (FDSs) are synthesized and secreted into the circulating hemolymph, which stimulates tissue growth systemically \[[@pbio.3000721.ref016]--[@pbio.3000721.ref021]\]. Subperineurial glia (SPG), a glial subtype that forms part of the blood brain-like barrier, respond to the FDS by synthesizing and secreting *Drosophila* insulin-like peptide 6 (Dilp-6) locally within the central nervous system (CNS) \[[@pbio.3000721.ref021]--[@pbio.3000721.ref023]\]. Local Dilp-6 activates the PI3-kinase pathway in neural stem cells, known as neuroblasts in *Drosophila*, leading to increased growth and their reactivation from developmental quiescence \[[@pbio.3000721.ref021],[@pbio.3000721.ref022]\]. This is the current model for how dietary nutrient conditions regulate neuroblast reactivation from developmental quiescence. What is lacking is a better understanding of how other cell types within the brain grow in response to dietary nutrients, whether their growth is coordinated in response to dietary nutrients, and whether their growth is required for neuroblast reactivation. Stem cells generally reside within specialized microenvironments, referred to as niches, that support and insulate them from outside factors \[[@pbio.3000721.ref024]\]. These specialized microenvironments integrate local and systemic cues to control stem cell proliferation decisions, cues that report on nutrient status, tissue physiology and function, and perhaps even developmental time.

Here, we report that in addition to neuroblast reactivation from developmental quiescence, animal feeding also initiates growth of glia and trachea. Moreover, growth of all 3 cell types occurs continuously and concomitantly, suggesting that common nutrient-sensing pathways regulate and coordinate growth among the different cell types in response to nutrition. We find that *Drosophila* insulin-like peptide 2 (Dilp-2) mediates PI3-kinase activation in neuroblasts and glia and that Dilp-2--mediated PI3-kinase activity is required to coordinate the growth of neuroblasts with the development of their cortex glial niche. Cortex glia, a subset of brain glia, ensheathe neuroblasts and their progeny with a selective membrane that provides barrier function to protect neuroblasts and their progeny from outside factors. Furthermore, we find that Dilp-6 is dispensable for neuroblast reactivation from quiescence, as well as the growth of glia and trachea in the brain, compensated for by high *dilp2* transcript and protein levels in response to feeding. This work highlights the importance of bidirectional growth signaling among different cell types in response to nutrition and sheds light on how dietary nutrients coordinate growth among different cell types within the developing *Drosophila* brain.

Results {#sec002}
=======

Neuroblast reactivation from quiescence, glial growth, and tracheal morphogenesis are nutrient regulated {#sec003}
--------------------------------------------------------------------------------------------------------

To better understand how cell growth is coordinated with tissue growth in response to dietary nutrients, we assayed proliferation and growth rates of different cell types in the *Drosophila* brain in response to animal feeding. Freshly hatched larvae were fed a standard fly food diet for defined periods of time (4, 12, 16, 20, or 24 hours), and growth and proliferation of neuroblasts, glia, and trachea were assayed in the brain ([Fig 1](#pbio.3000721.g001){ref-type="fig"}). Fly food was supplemented with EdU (5-ethynyl-2′-deoxyuridine) to assay S-phase entry, and size was measured based on the average diameter of neuroblasts or total membrane surface area for glia and trachea (see [Materials and Methods](#sec011){ref-type="sec"} for details). After 4 hours of animal feeding, we observed that the 4 mushroom body (MB) neuroblasts (white arrows) and 1 lateral neuroblast were dividing based on their incorporation of EdU and generation of EdU-positive progeny ([Fig 1A and 1F](#pbio.3000721.g001){ref-type="fig"} and [S1A--S1C Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). In contrast, the other central brain neuroblasts (approximately 100 per brain hemisphere), referred to as non-MB neuroblasts, failed to incorporate EdU during this time ([Fig 1A and 1F](#pbio.3000721.g001){ref-type="fig"} and [S1A--S1C Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). EdU-positive MB and lateral neuroblasts were larger than the EdU-negative, non-MB neuroblasts, but all expressed the HES1 orthologue, Deadpan (Dpn), a pan-neuroblast marker ([S1B and S1C Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). After 12 hours of feeding, a few non-MB neuroblasts incorporated EdU, and EdU incorporation correlated with increased neuroblast size ([Fig 1B and 1F](#pbio.3000721.g001){ref-type="fig"} and [S1F Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). Over time, the fraction of EdU-positive, non-MB neuroblasts continued to increase, and at 24 hours, more than 60% of non-MB neuroblasts were EdU-positive ([Fig 1C, 1D and 1F](#pbio.3000721.g001){ref-type="fig"}). Similar to earlier time points, EdU-positive non-MB neuroblasts were larger than EdU-negative non-MB neuroblasts ([S1D and S1F Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). To confirm that increases in neuroblast size and S-phase entry are nutrient regulated, we fed animals a sucrose-only diet for 24 hours. Consistent with previous reports, no neuroblasts other than the 4 MB neuroblasts (white arrows) and the lateral neuroblast incorporated EdU ([Fig 1E and 1F](#pbio.3000721.g001){ref-type="fig"}), and non-MB neuroblast size was reduced compared to both EdU-positive and negative non-MB neuroblasts from 24-hour--fed animals ([S1E and S1F Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). We conclude that neuroblasts reactivate from developmental quiescence in response to animal feeding and that reactivation occurs stepwise. Neuroblasts grow in size first and subsequently reenter S-phase and begin generating new progeny. This conclusion is in agreement with previously published work \[[@pbio.3000721.ref017],[@pbio.3000721.ref021],[@pbio.3000721.ref022],[@pbio.3000721.ref025],[@pbio.3000721.ref026]\].

![NB reactivation from quiescence, as well as glial and tracheal growth, are nutrient regulated.\
(A--E) Maximum intensity projections of single brain hemispheres. Top panels are colored overlays with single-channel grayscale images below. Brain hemispheres are outlined, and the dotted vertical line indicates the midline. Molecular markers are denoted within panels, and white arrows indicate MB NBs (A,E). (F) Quantification of EdU-positive NBs over time shown as scatter plots with dots representing individual brain hemispheres. Columns indicate mean and error bars indicate SEM in this and all subsequent figures. (G--L) Increases in glial membrane surface area over time in animals expressing mCD8:GFP using *repoGAL4*. (G--K) Single optical sections of brain hemispheres. Top panels are colored overlays, and bottom panels are single-channel images with mask overlays used in quantification (L) of total glial membrane surface area over time (see [Materials and Methods](#sec011){ref-type="sec"}). (M--R) Cerebral tracheal morphology over time in animals expressing GFP using *btlGAL4*. (M--Q) Maximum intensity projections of brain hemispheres with rendered trachea below and quantified in (R). (F,L,R) One-way ANOVA with Tukey post hoc analysis, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001. (A,G,M) Scale bar equals 10 μm in this and all subsequent figures. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. *btl*, *breathless*; Dpn, Deadpan; EdU, 5-ethynyl-2′-deoxyuridine; GFP, green fluorescent protein; mCD8, membrane-targeted CD8 antigen; NB, neuroblast; *repo*, *reversed polarity*; Scrib, Scribble.](pbio.3000721.g001){#pbio.3000721.g001}

Next, we asked whether growth of other cell types within the brain is also nutrient regulated. Nutrient-dependent growth of other cell types, including niche-like cortex glia, could play a role in regulating neuroblast reactivation from quiescence and contribute to the substantial increases in brain size observed after 24 hours of animal feeding (approximately 1.76×, [S1G Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). After 24 hours of feeding, we found that approximately 45% of glia, identified based on expression of the homeodomain transcription factor reversed polarity (Repo), incorporated EdU ([S1H and S1I Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). This was unexpected and suggested that either new glia are being produced or that existing glia endoreplicate in response to feeding. To distinguish between these possibilities, we counted glial nuclei before animal feeding (0 hours fed, freshly hatched) and after 24 hours of animal feeding. We found approximately 95 Repo-positive glia per brain hemisphere before feeding and approximately 100 after feeding, suggesting that EdU incorporation is not followed by glial cell division ([S1J Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). Next, we expressed upstream activating sequence (*UAS*)--*double-parked* RNA interference (*dupRNAi*) in glia (using *repoGAL4*) to inhibit DNA replication and block endoreplication \[[@pbio.3000721.ref027]\]. After 24 hours of feeding, essentially no *dupRNAi*-expressing glia were EdU-positive (\<1%, *n* = 5 brain hemispheres), and the glial number was unchanged compared to controls, indicating that glia endoreplicate in response to feeding ([S1K and S1L Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). Next, we expressed a membrane-tagged green fluorescent protein (GFP) in glia (*repoGAL4*, *UAS*--membrane-targeted CD8 antigen \[*mCD8*\]*GFP*) to assay glial surface area over time. Between 12 and 24 hours of animal feeding, glial membrane surface area increased nearly 3-fold ([Fig 1G--1J](#pbio.3000721.g001){ref-type="fig"} and [1L](#pbio.3000721.g001){ref-type="fig"}). To determine whether glial membrane growth and S-phase entry are nutrient regulated, animals were fed a sucrose-only diet. After 24 hours, no increases in glia membrane surface area or EdU-positive glia were found, demonstrating that glial membrane growth and S-phase entry are nutrient regulated ([Fig 1K and 1L](#pbio.3000721.g001){ref-type="fig"} and [S1I Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). We conclude that glia endoreplicate and their membrane surface area increases in response to dietary nutrients.

Next, we assayed growth of brain trachea in response to feeding. Trachea are a network of epithelial-derived tubules that supply oxygen and exchange gas throughout the animal. In the brain, during later larval stages, trachea extend along glia forming a perineuropilar tracheal plexus, analogous to cerebral vasculature in mammals \[[@pbio.3000721.ref028]\]. During mammalian cortical development, intermediate neural progenitors divide near blood vessel branch points, suggesting that cerebral vasculature provides niche-like support, similar to *Drosophila* glia \[[@pbio.3000721.ref029]\]. To determine whether tracheal morphogenesis in the *Drosophila* brain is nutrient regulated, we assayed tracheal growth over time in response to feeding. Before animal feeding, a single tracheal branch enters the medial brain region \[[@pbio.3000721.ref028]\]. After 24 hours of feeding, we observed 1 to 4 EdU-positive tracheal nuclei, located at the base of secondary branches, in each brain hemisphere ([S1M and S1N Fig](#pbio.3000721.s001){ref-type="supplementary-material"}), and we found an overall 3-fold increase in tracheal surface area ([Fig 1M--1P](#pbio.3000721.g001){ref-type="fig"} and [1R](#pbio.3000721.g001){ref-type="fig"}). Tracheal branching became more elaborate over time, with brain hemispheres being infiltrated from the inside out in a stereotypic pattern. In contrast, when animals were fed a sucrose-only diet, no EdU-positive tracheal nuclei were observed, and tracheal surface area and branching was reduced ([Fig 1Q and 1R](#pbio.3000721.g001){ref-type="fig"} and [S1N Fig](#pbio.3000721.s001){ref-type="supplementary-material"}). Together, we conclude that growth (S-phase entry and size) of neuroblasts, glia, and trachea is nutrient regulated. Moreover, growth of all 3 cell types occurs continuously and concomitantly, raising the possibility that nutrient-sensing pathways coordinate growth among different cell types.

Nutrient-dependent growth of neuroblasts, glia, and trachea requires cell-autonomous and non-cell--autonomous activation of PI3-kinase {#sec004}
--------------------------------------------------------------------------------------------------------------------------------------

Increases in cell growth in response to dietary nutrients are typically due to increased PI3-kinase pathway activity, an evolutionarily conserved growth signaling pathway that activates TOR-kinase and other growth pathways \[[@pbio.3000721.ref001],[@pbio.3000721.ref003],[@pbio.3000721.ref007],[@pbio.3000721.ref009],[@pbio.3000721.ref014]\]. To determine whether PI3-kinase is required for nutrient-dependent growth of neuroblasts, glia, and trachea, we expressed *UAS-Drosophila protein 60* (*dp60*) to reduce PI3-kinase activity cell autonomously using cell-type--specific GAL4 lines and assayed EdU incorporation and cell size or membrane surface area after 24 hours of feeding ([Fig 2A](#pbio.3000721.g002){ref-type="fig"} and [S2A--S2F Fig](#pbio.3000721.s002){ref-type="supplementary-material"}) \[[@pbio.3000721.ref030]\]. When levels of PI3-kinase activity were reduced in neuroblasts (*worniu* \[*wor*\]*GAL4*, *UAS-dp60*), neuroblast EdU incorporation was reduced and neuroblast size reduced as reported previously ([S2A and S2B Fig](#pbio.3000721.s002){ref-type="supplementary-material"}) \[[@pbio.3000721.ref021],[@pbio.3000721.ref022],[@pbio.3000721.ref026]\]. When levels of PI3-kinase activity were reduced in all glia (*repoGAL4*, *UAS-dp60*), EdU incorporation was essentially absent in glia, and the membrane surface area was reduced ([S2C and S2D Fig](#pbio.3000721.s002){ref-type="supplementary-material"}). Reduction of PI3-kinase activity in trachea (*btlGAL4*, *UAS-dp60*) resulted in reduced EdU incorporation and tracheal surface area and branching ([S2E and S2F Fig](#pbio.3000721.s002){ref-type="supplementary-material"}). Therefore, PI3-kinase is required for cell-autonomous nutrient-dependent growth of neuroblasts, glia, and trachea.

![Nutrient-dependent growth of NBs, glia, and trachea requires cell-autonomous and non-cell--autonomous PI3-kinase activation.\
(A) Images of segmented brain hemispheres with cell types colored as indicated. (B--D) Single Z images of brain hemispheres. Top panels are colored overlays, and bottom panel are single-channel images overlaid with the mask used for quantification (E) (see [Materials and Methods](#sec011){ref-type="sec"}). (F,G,J) EdU-positive NBs after 24 hours of feeding. Maximum intensity projections of brain hemispheres from the indicated genotypes. Top panels are colored overlays, and single-channel grayscale images are below. Brain hemispheres are outlined, and the dotted vertical line to the left indicates the midline. Quantification of EdU-positive NBs (H,K) and NB size (I). (L) Summary of PI3-kinase growth regulation between different cell types in the brain. Circular arrows indicate requirement for autonomous PI3-kinase growth signaling, and straight arrows indicate nonautonomous growth signaling. (E) One-way ANOVA with Tukey post hoc analysis. (H,I,K) Student two-tailed *t* test, \**p* \< 0.05, \*\**p* \< 0.01,\*\*\**p* \< 0.001, error bars, SEM. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. *btl*, *breathless*; Dpn, Deadpan; *dp60*, *Drosophila protein 60*; EdU, 5-ethynyl-2′-deoxyuridine; GFP, green fluorescent protein; mCD8, membrane-targeted CD8 antigen; NB, neuroblast; PI3-kinase, phosphoinositide 3-kinase; *raptorRNAi*, *raptor* RNA interference; *repo*, *reversed polarity*; *UAS*, upstream activating sequence; *wor*, *worniu*.](pbio.3000721.g002){#pbio.3000721.g002}

To determine whether PI3-kinase is also required to coordinate growth among neuroblasts, glia, and trachea in response to nutrition, levels of PI3-kinase activity were reduced in 1 cell type (neuroblasts, glia, or trachea) alone, and the growth of the other 2 cell types was assayed. When PI3-kinase levels were reduced in neuroblasts (*worGAL4*, *UAS-dp60*), a modest but significant reduction in glial membrane surface area was observed after 24 hours of feeding ([Fig 2A--2C](#pbio.3000721.g002){ref-type="fig"} and [2E](#pbio.3000721.g002){ref-type="fig"}). To further support that neuroblast growth is required for glial growth, we expressed *raptorRNAi* in neuroblasts (*worGAL4*, *UAS-raptorRNAi*) to knock down TOR activity. Again, a significant reduction in glial membrane surface area was found after 24 hours of feeding ([Fig 2D and 2E](#pbio.3000721.g002){ref-type="fig"}). Reductions in glial membrane surface area could be due to reductions in glia number because some *worGAL4*-expressing neuroblast lineages generate glia. Indeed, glia number was reduced compared with controls in *raptorRNAi* knockdown animals (*worGAL4*, *UAS-raptorRNAi*) but remained unchanged when PI3-kinase activity was reduced in neuroblasts (*worGAL4*, *UAS-dp60*) ([S2G Fig](#pbio.3000721.s002){ref-type="supplementary-material"}). Next, we assayed tracheal surface area when levels of PI3-kinase activity were reduced in neuroblasts. No change in tracheal surface area was detected ([S2H--S2J Fig](#pbio.3000721.s002){ref-type="supplementary-material"}). We conclude that activation of PI3-kinase signaling in neuroblasts is required for glial membrane growth, but not for growth of trachea.

Next, we reduced PI3-kinase activity in glia and assayed the growth of neuroblasts and trachea. When PI3-kinase levels were reduced in glia (*repoGAL4*, *UAS-dp60*), significant reductions in both neuroblast EdU incorporation and neuroblast size were found after 24 hours of feeding ([Fig 2F--2I](#pbio.3000721.g002){ref-type="fig"}). Yet, tracheal surface area remained relatively unchanged compared to controls ([S2K and S2L Fig](#pbio.3000721.s002){ref-type="supplementary-material"}). Finally, we reduced PI3-kinase activity in trachea and assayed the growth of neuroblasts and glia. When PI3-kinase activity levels were reduced in trachea (*btlGAL4*, *UAS-dp60*), we found a modest but significant reduction in neuroblast EdU incorporation after 24 hours of feeding ([Fig 2J and 2K](#pbio.3000721.g002){ref-type="fig"}) but no change in glia membrane surface area ([S2M and S2N Fig](#pbio.3000721.s002){ref-type="supplementary-material"}). We conclude that activation of PI3-kinase signaling in glia and trachea both contribute to neuroblast reactivation, revealing that both cell types provide niche-like stem cell support. In addition, activation of PI3-kinase in neuroblasts is required for glial growth, but not tracheal growth (summary panel [Fig 2L](#pbio.3000721.g002){ref-type="fig"}). Altogether, we conclude that PI3-kinase signaling functions in a cell-autonomous and nonautonomous manner to coordinate growth among different cell types within the developing *Drosophila* brain.

Growth of cortex, subperineurial, and neuropil glia is nutrient regulated and PI3-kinase dependent {#sec005}
--------------------------------------------------------------------------------------------------

The glial population in the *Drosophila* brain is composed of several different subtypes, including cortex glia that ensheathe neuroblasts and their newborn neuron progeny, SPG that encapsulate the CNS and form part of the \"blood-brain--like barrier\", and neuropil glia that separate neuron cell bodies from their axon projections ([S3A Fig](#pbio.3000721.s003){ref-type="supplementary-material"}). To better understand how PI3-kinase--dependent growth is coordinated between neuroblasts and glia, we assessed numbers and types of glia, based on location, before and after animal feeding. Before feeding, approximately 95 Repo-positive glia were found in each brain hemisphere. Of these, approximately 18 were cortex glia (19%), approximately 34 were neuropil glia (35%, which include ensheathing glia of the neuropil and astrocytes), and the rest, approximately 46%, were SPG and optic-lobe--associated glia combined. After 24 hours of feeding, glial number and subtype distribution based on location remained relatively similar ([S3B Fig](#pbio.3000721.s003){ref-type="supplementary-material"}). We conclude that glial number and type are not specified by dietary nutrient uptake.

Next, we screened existing glial GAL4 lines to identify lines that drive GAL4 reporter expression specifically in different glial subsets in 24-hour--fed animals ([S1 Table](#pbio.3000721.s006){ref-type="supplementary-material"}). We found that *NP0577GAL4* drove *UAS-histone* red fluorescent protein (*RFP*) reporter expression in all cortex glia, identified based on location and Repo coexpression, as well as in some other glia ([S3C and S3D Fig](#pbio.3000721.s003){ref-type="supplementary-material"} and [S1 Table](#pbio.3000721.s006){ref-type="supplementary-material"}). *MoodyGAL4* drove *UAS-histoneRFP* in most SPG, almost half of neuropil glia, but no other glia ([S3E and S3F Fig](#pbio.3000721.s003){ref-type="supplementary-material"} and [S1 Table](#pbio.3000721.s006){ref-type="supplementary-material"}). Of the 6 glial GAL4 lines screened, *NP0577GAL4* and *moodyGAL4* exhibited the most restricted and specific patterns of glia GAL4 expression in brains of 24-hour--fed animals. Therefore, we used these lines for subsequent analyses.

We expressed a membrane-tagged GFP in cortex glia (*NP0577GAL4*, *UAS-mCD8GFP*) to assay membrane growth in this glial subtype. After 24 hours of feeding, cortex glial membrane surface area increased nearly 3-fold, and cortex glia began to ensheathe neuroblasts with new glial membrane ([Fig 3A and 3D](#pbio.3000721.g003){ref-type="fig"}). In contrast, animals fed a sucrose-only diet or a normal diet with reduced PI3-kinase levels in cortex glia (*NP0577GAL4*, *UAS-dp60*) showed no increases in cortex glia membrane surface area after 24 hours ([Fig 3B--3D](#pbio.3000721.g003){ref-type="fig"}). Furthermore, we found no evidence of glial membrane ensheathment of neuroblasts under these conditions ([Fig 3B and 3C](#pbio.3000721.g003){ref-type="fig"}, right panels). Next, we carried out a similar set of experiments in *moodyGAL4*, *UASmCD8GFP* animals. In animals fed a sucrose-only diet or those fed a normal diet but with reduced PI3-kinase levels in glia (*moodyGAL4*, *UAS-dp60*), we observed reductions in SPG and neuropil glial membrane surface area compared to animals fed a normal diet for 24 hours ([Fig 3E--3H](#pbio.3000721.g003){ref-type="fig"}). Of note, neither SPG nor neuropil glia ensheathed neuroblasts ([Fig 3E](#pbio.3000721.g003){ref-type="fig"}, right panel). We conclude that cortex glia, SPG, and neuropil glia require dietary nutrients and PI3-kinase activity for growth. Importantly, glial-subtype--specific GAL4 lines provide the tools necessary to further dissect nonautonomous growth regulation between neuroblasts and specific glia subtypes in response to nutrition and PI3-kinase activity levels.

![Growth of cortex glia and SPG is nutrient regulated and PI3-kinase dependent.\
(A-C) Cortex glial membrane morphology after 24 hours of feeding standard food (A and C) or sucrose (B). (A--C) Single Z planes of brain hemispheres. Top panels are colored overlays, and bottom panels are single-channel images with the mask overlays used for quantification of cortex glia membrane surface area (D). Boxed Dpn-positive NBs are shown at higher magnification to the right. (E--G) SPG and neuropil glial membrane morphology after 24 hours of feeding on standard food (E and G) or sucrose (F). (J--L) Single Z images of brain hemispheres. Top panels are colored overlays, and bottom panels show single-channel images with the mask overlay used for quantification of SPG and neuropil membrane surface area (H). Dpn-positive NBs denoted in the box shown at higher magnification to the right. One-way ANOVA with Tukey post hoc analysis, \*\**p* \< 0.01, \*\*\**p* \< 0.001. Error bars, SEM. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. Dpn, Deadpan; *dp60*, *Drosophila protein 60*; GFP, green fluorescent protein; mCD8, membrane-targeted CD8 antigen; NB, neuroblast; PI3-kinase, phosphoinositide 3-kinase; Scrib, Scribble; SPG, subperineurial glia; *UAS*, upstream activating sequence.](pbio.3000721.g003){#pbio.3000721.g003}

Cortex glia are required to reactivate neuroblasts from developmental quiescence {#sec006}
--------------------------------------------------------------------------------

We found that reduction of PI3-kinase activity in all glia inhibited neuroblast reactivation from developmental quiescence (refer back to [Fig 2F--2I](#pbio.3000721.g002){ref-type="fig"}). Using glial-subtype--specific GAL4 lines, we reduced PI3-kinase levels in a glial-subtype--specific manner and assayed neuroblast EdU incorporation and size after 24 hours of feeding. When PI3-kinase activity was reduced in cortex glia (*NP0577GAL4*, *UAS-dp60*), we found that neuroblast EdU incorporation and size were reduced after 24 hours of animal feeding ([Fig 4A, 4B, 4D and 4E](#pbio.3000721.g004){ref-type="fig"}). The same effect was observed when phosphatidylinositol (3,4,5)-trisphosphate (PIP~3~) levels were reduced by overexpressing the lipid phosphatase, phosphatase and tensin homolog (Pten) (*NP0577GAL4*, *UAS-Pten*) ([Fig 4D](#pbio.3000721.g004){ref-type="fig"}). However, when PI3-kinase activity levels were reduced in SPG/neuropil glia (*moodyGAL4*, *UAS-dp60)*, no difference in neuroblast EdU incorporation was found compared to controls ([Fig 4F--4H](#pbio.3000721.g004){ref-type="fig"}). Next, *UAS-dp60* was simultaneously expressed in both cortex glia and trachea. A significant reduction in neuroblast EdU incorporation was found compared to animals expressing *UAS-dp60* alone in either cortex glia (*NP0577GAL4*) or trachea (*btlGAL4*) ([Fig 4I](#pbio.3000721.g004){ref-type="fig"}). Finally, to confirm that cortex glia are indeed required for neuroblast reactivation, the proapoptotic gene *grim* was expressed *(NP0577GAL4*, *UAS-grim)* to ablate cortex glia genetically ([Fig 4J--4L](#pbio.3000721.g004){ref-type="fig"}). After 24 hours of feeding, neuroblast EdU incorporation was essentially absent, and neuroblast size was reduced compared with controls ([Fig 4C--4E](#pbio.3000721.g004){ref-type="fig"}). We conclude that neuroblast growth and reactivation from quiescence requires activation of PI3-kinase in cortex glia, the glial subtype that ensheathes neuroblasts and their newborn progeny, but not SPG or neuropil glia. Furthermore, activation of PI3-kinase growth signaling in both trachea and cortex glia together promote neuroblast reactivation from developmental quiescence.

![Cortex glia are required for nutrient-dependent NB reactivation from quiescence.\
(A--D) EdU-positive NBs in animals with genetic manipulations in cortex glia at 24 hours after feeding. (A--C) Maximum intensity projections of brain hemispheres. Top panels are colored overlays, and bottom panels show single-channel grayscale images. Brain hemispheres are outlined, and the dotted vertical lines indicate the midline. Graphs show quantification of EdU-positive NBs per brain hemisphere (D) and NB size based on EdU incorporation (E). Numbers in E indicate the number of NBs analyzed. (F--H) EdU-positive NBs in animals with genetic manipulations in SPG and neuropil glia at 24 hours after feeding. (F--G) Maximum intensity projections of brain hemispheres. Panels are colored overlays (top), with single-channel grayscale images below. Brain hemispheres are outlined, and dotted vertical lines indicate the midline. Quantification of EdU-positive NBs per brain hemisphere (H). (I) Quantification of EdU-positive NBs per brain hemisphere of indicated genotypes. (J) Single Z-plane image, top panel is a colored overlay with single-channel grayscale image below, brain hemisphere outlined. (K) Two (top and bottom) grayscale images of same Z-plane, with quantification of cortex glia number following genetic ablation quantified in (L). (D,I) One-way ANOVA with Tukey post hoc analysis and (E,H,L) Student two-tailed *t* test, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. *btl*, *breathless*; Dpn, Deadpan; *dp60*, *Drosophila protein 60*; EdU, 5-ethynyl-2′-deoxyuridine; mCD8, membrane-targeted CD8 antigen; NB, neuroblast; O/E, overexpression; Pten, phosphatase and tensin homolog; Repo, reversed polarity; *RFP*, red fluorescent protein; Scrib, Scribble; SPG, subperineurial glia; *UAS*, upstream activating sequence.](pbio.3000721.g004){#pbio.3000721.g004}

Dilp-2 regulates neuroblast reactivation and cortex glia membrane growth, but not growth of trachea {#sec007}
---------------------------------------------------------------------------------------------------

PI3-kinase is activated in response to feeding, after any one of the 7 *Drosophila* insulin-like peptides (Dilps1--7) bind to and activate the single insulin-like tyrosine kinase receptor (InR). While a role in neuroblast reactivation has been attributed to Dilps \[[@pbio.3000721.ref021]--[@pbio.3000721.ref023]\], a systematic analysis of each of the *dilp* mutants is still lacking. To better understand how PI3-kinase coordinates growth among different cell types within the developing brain, we assayed neuroblast EdU incorporation in each of the 7 *dilp* null mutants. Compared to controls and other *dilp* mutants, neuroblast EdU incorporation in the brain was reduced in *dilp1*, *dilp2*, and *dilp7* null mutants after 24 hours of feeding ([Fig 5A](#pbio.3000721.g005){ref-type="fig"}). Of these, *dilp2* mutants displayed the most severe and penetrant reductions in neuroblast EdU incorporation and neuroblast size ([Fig 5A--5D](#pbio.3000721.g005){ref-type="fig"} and [S4A Fig](#pbio.3000721.s004){ref-type="supplementary-material"}). To confirm that reduced neuroblast EdU incorporation was due to the absence of *dilp2* and not a second background mutation, we assayed EdU incorporation in animals transheterozygous for the *dilp2* null allele over a small deficiency that removes *dilp2* and the neighboring *dilp3* locus. The number of EdU-positive neuroblasts after 24 hours of feeding in transheterozygous larvae was indistinguishable from *dilp2*^*1*^ homozygotes ([Fig 5A](#pbio.3000721.g005){ref-type="fig"}). We conclude that Dilp-1, Dilp-2, and Dilp-7 regulate neuroblast reactivation from quiescence in the brain.

![Dilp-2 regulates NB reactivation and cortex glial membrane growth.\
(A--D) EdU-positive NBs after 24 hours of feeding in *dilp* single-null--mutant animals with quantification (A) shown as a scatter plot with dots indicating brain hemispheres, bars indicating means, and error bars SEM. (B--D) Maximum intensity projections of brain hemispheres. Top panels are colored overlays with single-channel grayscale images below. Brain hemispheres are outlined, and dotted vertical lines indicate the midline. (E--G) Cortex glial membrane morphology after 24 hours of feeding in controls and *dilp2* mutants. (E,F) Single Z images of brain hemispheres. Top panels are colored overlays, and bottom panels are single-channel images with the mask overlays used for quantification in (G). (H--J) Cerebral tracheal morphology after 24 hours of feeding in controls and *dilp2* mutants. (H,I) Maximum intensity projections of brain hemispheres with rendered trachea below and quantified in (J). (A,G) One-way ANOVA with Tukey post hoc analysis and (J) Student two-tailed *t* test, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. Dilp, *Drosophila* insulin-like peptide; Dlg, discs-large; Dpn, Deadpan; EdU, 5-ethynyl-2′-deoxyuridine; GFP, green fluorescent protein; mCD8, membrane-targeted mCD8 antigen; NB, neuroblast; n.s., not significant; Scrib, Scribble.](pbio.3000721.g005){#pbio.3000721.g005}

Given the prominent role of Dilp-2 in neuroblast growth and reactivation in the brain, we next asked whether Dilp-2 is also required for cortex glial and tracheal growth in response to animal feeding. Compared to controls, cortex glial membrane surface area was reduced by half in *dilp2* mutants and in animals transheterozygous for the *dilp2* null allele over the *dilp2*, *dilp3* deficiency after 24 hours of feeding ([Fig 5E--5G](#pbio.3000721.g005){ref-type="fig"}). In contrast, tracheal surface area remained unchanged ([Fig 5H--5J](#pbio.3000721.g005){ref-type="fig"}). Next, we assayed neuroblast reactivation and cortex glial membrane surface area at 48 hours ALH (after larval hatching). No difference in number of EdU-positive neuroblasts or glial cortex membrane surface was observed between controls and *dilp2* mutants ([S4B and S4C Fig](#pbio.3000721.s004){ref-type="supplementary-material"}). Because *dilp2* mutants reportedly delay development anywhere from 8 to 16 hours from egg to adult \[[@pbio.3000721.ref045]\], we assayed mouth hook morphology as a proxy for larval stage. No difference between controls and *dilp2* mutants was observed at 24 or 48 hours ALH, suggesting that *dilp2* null mutants are not developmentally delayed during early larval stages ([S4D and S4E Fig](#pbio.3000721.s004){ref-type="supplementary-material"}). We conclude that Dilp-2 is required for cortex glial membrane growth, but not tracheal growth. Furthermore, because Dilp-2 is also required for neuroblast growth and reactivation, it suggests that growth coordination between cortex glia and neuroblasts is Dilp-2 dependent.

Dilp-2 regulates CNS Dilp-6 protein levels, but not *dilp6* transcript levels {#sec008}
-----------------------------------------------------------------------------

Somewhat surprisingly, neuroblast EdU incorporation in brains of *dilp6* null-mutant animals was not different compared with controls, *dilp3*, *dilp4*, or *dip5* mutants, nor was neuroblast size affected by loss of *dilp6* ([Fig 5A, 5B and 5D](#pbio.3000721.g005){ref-type="fig"} and [S4A Fig](#pbio.3000721.s004){ref-type="supplementary-material"}). This was unexpected because Dilp-6 is reported to be synthesized and secreted from SPG in response to animal feeding, leading to PI3-kinase activation and reactivation of adjacent quiescent neuroblasts in the ventral nerve cord (VNC) \[[@pbio.3000721.ref021]--[@pbio.3000721.ref023]\]. However, neuroblasts located within different CNS regions, brain versus VNC, could have different requirements for reactivation based on neuroblast intrinsic differences and/or differences in tissue architecture. To determine whether Dilp-6 regulates growth of other cell types within the brain, we assayed glial and tracheal surface area in *dilp6* mutants after 24 hours of feeding. No differences were observed compared to controls ([Fig 6A--6F](#pbio.3000721.g006){ref-type="fig"}). To determine whether Dilp-2 masks Dilp-6 function in the brain, we assayed neuroblast EdU incorporation and size in *dilp2*, *dilp6* double-mutant animals. After 24 hours of feeding, neuroblast EdU incorporation was reduced in *dilp2*, *dilp6* double mutants (approximately 15% EdU-positive neuroblasts) compared with *dilp2* single mutants (approximately 22% EdU-positive neuroblasts); however, this reduction was not statistically different ([S5A and S5B Fig](#pbio.3000721.s005){ref-type="supplementary-material"}). Next, we assayed *dilp2* and *dilp6* transcript levels ([Fig 6G and 6H](#pbio.3000721.g006){ref-type="fig"}), and endogenous Dilp-2 and Dilp-6 protein levels ([Fig 6I](#pbio.3000721.g006){ref-type="fig"}) in the CNS of wild-type animals after feeding. We found that Dilp-2 transcript and protein levels were approximately 80 times higher than Dilp-6 transcript and protein levels, consistent with the notion that Dilp-2 is the predominant Dilp in the central brain ([Fig 6G--6I](#pbio.3000721.g006){ref-type="fig"}). Furthermore, in *dilp2* mutants, we found that *dilp6* transcript levels were not different from wild-type control levels, although Dilp-6 protein levels were significantly reduced compared to control animals ([Fig 6H and 6J](#pbio.3000721.g006){ref-type="fig"}). We conclude that Dilp-2 is the primary Dilp regulating PI3-kinase--dependent growth of neuroblasts, glia, and trachea in the brain and that Dilp-2 directly or indirectly regulates Dilp-6 protein levels.

![Dilp-2 regulates Dilp-6 CNS protein levels.\
(A--C) Glial membrane morphology after 24 hours of feeding in controls and *dilp6* mutants. (A,B) Single Z images of brain hemispheres. Panels are colored overlays (top) and single-channel images with mask overlays (bottom) used for quantification of total glial membrane surface (C). (D--F) Cerebral tracheal morphology after 24 hours of feeding in controls and *dilp6* mutants. (D,E) Maximum intensity projections of brain hemispheres with rendered trachea below and quantified in (F). (G,H) RT-qPCR analysis of *dilp2* and *dilp6* transcript levels in the CNS of wild-type and *dilp2* mutant animals after 24 hours of feeding. Transcript levels of *dilp2* and *dilp6* are normalized to *Gapdh1* and then to *dilp6* levels in wild-type animals. (I,J) Brain Dilp-2 and Dilp-6 protein levels, normalized to total brain protein, in wild-type and *dilp2* mutant animals after 72 hours of feeding. (K) Quantification of EdU-positive NBs in the indicated genotypes after 24 hours of feeding. (C,F,J) Student two-tailed *t* test; (K) one-way ANOVA with Tukey post hoc analysis and \*\**p* \< 0.01, \*\*\**p* \< 0.001. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. a.u., arbitrary unit; CNS, central nervous system; Dilp, *Drosophila* insulin-like peptide; Dpn, Deadpan; EdU, 5-ethynyl-2′-deoxyuridine; *Gapdh1*, Glyceraldehyde-3-phosphate dehydrogenase; GFP, green fluorescent protein; HF, HA-FLAG tag; mCD8, membrane-targeted CD8 antigen; NB, neuroblast; RT-qPCR, real-time qPCR; Scrib, Scribble; *UAS*, upstream activating sequence.](pbio.3000721.g006){#pbio.3000721.g006}

Next, we carried out a series of rescue experiments in *dilp2* mutants to identify the cell source of Dilp-2 required for neuroblast reactivation. When *UAS-dilp2* was expressed in insulin-producing cells (IPCs, *dilp2 GAL4*), neuroblast EdU incorporation was rescued in *dilp2* mutants ([Fig 6K](#pbio.3000721.g006){ref-type="fig"}). Similarly, expression of *UAS-dilp2* in SPG (*moodyGAL4*) also rescued neuroblast EdU incorporation in *dilp2* mutants. Because Dilp-2 is normally expressed in the IPCs \[[@pbio.3000721.ref042],[@pbio.3000721.ref043]\] and not BBB (blood--brain barrier) glia, this suggests that Dilp-2 is required in IPCs for neuroblast reactivation in the brain. In contrast, expression of *UAS-dilp6* in IPCs did not rescue neuroblast EdU incorporation in *dilp2* mutants. We conclude that Dilp-2 is required in the IPCs for neuroblast reactivation from developmental quiescence in the brain hemispheres.

Coordination of growth between neuroblasts and cortex glia promotes formation of a selective membrane barrier for niche stem cell support {#sec009}
-----------------------------------------------------------------------------------------------------------------------------------------

During later stages of larval development, neuroblasts and their progeny reside within characteristic glial membrane-bound pockets ([Fig 7A and 7B](#pbio.3000721.g007){ref-type="fig"}). One or two cortex glia that lie nearby or adjacent to neuroblasts and their progeny provide the membrane that constitutes each pocket. We injected a fluorescently conjugated 10-kDa dextran directly into the brain to test the permeability of glia membrane-bound pockets. We found fluorescent dextran colocalized with cortex glia membrane along the outside of each pocket, but we did not find fluorescence within the pocket ([Fig 7A](#pbio.3000721.g007){ref-type="fig"}). This suggests that cortex glia form a membrane barrier that selectively regulates passage of factors based on size.

![Cortex glia ensheathe NBs and their progeny and provide a niche-like barrier function.\
(A) Top panel, colored overlay with RFP marking glial membranes and GFP marking *pcnaGFP*-expressing NBs. Middle panel, single-channel grayscale image of 10-kDa dextran. Bottom panel, colored overlay with 10-kDa dextran and RFP marking glial membranes. To the right, high-magnification images of the boxed NB, with double-labeled glial membrane in a 72-hour--fed animal after dextran injection (see [Materials and Methods](#sec011){ref-type="sec"}). (B) Cortex glia ensheathe NBs (white bracket) and their newborn progeny, which express high levels of Scrib. Top panel, colored overlay. Middle panel, single-channel image with GFP marking glial membranes. Bottom panel is a depiction of the glial and NB segments used for quantification in (C,D,K) (see [Materials and Methods](#sec011){ref-type="sec"}). (C,D) Percentage of NB membrane in contact with glial contact over time. Colored circles in (C) indicate individual NBs, and colored circles in (D) indicate averages for the indicated time points. Both are plotted relative to NB area. (E--G) Increasing surface contact between NBs and glia membrane over time. Single Z-plane of representative NBs at different time points after feeding. Top panels are colored overlays, middles panels are single-channel images, and bottom panels depict the glial NB segment and NB segment used in quantification (C--D). (H--K) Top panel colored overlay, middle panel single-channel image, and bottom panel glial NB segment and NB segment used in quantification of animals at 24 hours of feeding with genotypes listed above. (D,K) One-way ANOVA with Tukey post hoc analysis, \*\*\**p* \< 0.001. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. Dilp, *Drosophila* insulin-like peptide; GFP, green fluorescent protein; mCD8, membrane-targeted CD8 antigen; NB, neuroblast; *pcna*, proliferating cell nuclear antigen; *repo*, *reversed polarity*; RFP, red fluorescent protein; Scrib, Scribble; *UAS*, upstream activating sequence.](pbio.3000721.g007){#pbio.3000721.g007}

Next, we investigated whether Dilp-2--mediated PI3-kinase activation in neuroblasts and glia is required for glia pocket formation. First, we measured the fraction of neuroblast membrane, marked by endogenous expression of Scribble (Scrib), in contact with glia membrane, marked by transgenic expression of *UAS-mCD8*:*GFP* (% neuroblast membrane with glial contact; see [Materials and Methods](#sec011){ref-type="sec"}) over time in control animals ([Fig 7B](#pbio.3000721.g007){ref-type="fig"}, schematic at bottom). From 0 hour freshly hatched stages until 8 hours after feeding, we found that the fraction of neuroblast membrane in contact with glial membrane increased approximately 3.5-fold ([Fig 7C--7F](#pbio.3000721.g007){ref-type="fig"}). At 24 hours after feeding, glia ensheathe approximately 44% of the neuroblast membrane, and at 72 hours after feeding, they ensheathe approximately 72% ([Fig 7B--7D](#pbio.3000721.g007){ref-type="fig"} and [7G](#pbio.3000721.g007){ref-type="fig"}). Next, we assessed the temporal relationship between neuroblast--glial membrane contact and changes in neuroblast size. We found that neuroblast size began to increase 16 hours after feeding, after the fraction of neuroblast--glial contact increased ([Fig 7C--7G](#pbio.3000721.g007){ref-type="fig"}). Next, we measured the fraction of neuroblast membrane in contact with glia membrane in 24-hour--fed *dilp2* mutants ([Fig 7I and 7K](#pbio.3000721.g007){ref-type="fig"}). We found significant reductions in neuroblast membrane and glia membrane contact that correlated with reductions in neuroblast size. A similar result was found when levels of PI3-kinase activity were reduced in glia, but not in neuroblasts ([Fig 7H, 7J and 7K](#pbio.3000721.g007){ref-type="fig"}). In neuroblasts, when PI3-kinase activity levels were reduced, neuroblast size remained reduced compared to controls, but increases in neuroblast membrane in contact with glial membrane were found. We conclude that Dilp-2 mediated PI3-kinase activation is required to initiate glial pocket formation. Importantly, increases in neuroblast membrane with glia contact precede increases in neuroblast size, consistent with the notion that cortex glia membrane contact triggers neuroblast growth and reactivation.

Discussion {#sec010}
==========

Here, we report that different cell types in the brain utilize the same evolutionarily conserved cell signaling pathway, PI3-kinase, to promote growth in response to dietary nutrients. PI3-kinase is a lipid kinase that converts PIP~2~ to PIP~3~ at the plasma membrane when active, leading to downstream Akt/PKB (Protein Kinase B) activation and nuclear exclusion of forkhead box, subgroup O (Foxo), a transcription factor and negative regulator of growth \[[@pbio.3000721.ref031]--[@pbio.3000721.ref034]\]. We found that active PI3-kinase not only regulates cell growth autonomously in the brain but also regulates growth of other cell types in a nonautonomous manner. For example, glial growth is reduced when PI3-kinase levels are reduced in neuroblasts. The molecular basis for this reduction is not yet known, but reactivated and proliferating neuroblasts with active PI3-kinase may express or secrete factors on their cell surface that promote glial growth nonautonomously. These could include PDGF- and VEGFR-receptor related (PVR) (Platelet-derived growth factor receptor \[PDGFR\] orthologue) ligands, secreted growth factors, or components of the Hippo or Notch cell signaling pathways that would not normally be expressed in quiescent neuroblasts having low to no PI3-kinase activity \[[@pbio.3000721.ref035]--[@pbio.3000721.ref037]\]. We also found that PI3-kinase--dependent growth of cortex glia is required for neuroblast reactivation and that cortex glia membrane ensheathes neuroblasts before they increase in size. The glial process that makes first contact with a neuroblast could deliver signaling molecules to stimulate neuroblast reactivation from quiescence, similar to cytonemes or nanotubules, or simply supply a foreign membrane that stimulates growth \[[@pbio.3000721.ref038],[@pbio.3000721.ref039]\]. We also found that neuroblasts rely on PI3-kinase-dependent growth of trachea for reactivation. Trachea allow for oxygen exchange, but they are also important sources of cell signaling molecules, including EGF-R and FGF-R. Whether neuroblast quiescence versus proliferation decisions are regulated by oxygen levels has yet to be determined, but quiescent adult stem cells in other organisms are thought to reside within hypoxic microenvironments \[[@pbio.3000721.ref040],[@pbio.3000721.ref041]\].

Of all the Dilps, we found that Dilp-2 plays a predominant role in mediating PI3-kinase--dependent growth of neuroblasts and glia as well as neuroblast reactivation. This was not expected based on previous reports; however, neuroblasts with different intrinsic programs located within different regions of the CNS (brain versus VNC) could reactivate in a different manner. In the brain, Dilp-2 is synthesized and secreted in a dietary-nutrient--dependent manner from 14 neurosecretory neurons, the IPCs, located along the anterior midline \[[@pbio.3000721.ref042],[@pbio.3000721.ref043]\]. Axons of these neurosecretory neurons, known as the IPCs, terminate on the dorsal vessel, which pumps hemolymph, and thus Dilp-2, systemically throughout the body \[[@pbio.3000721.ref043]\]. Dilp-2 is also released locally in the brain through IPC connections with other neurosecretory neurons, including the centrally located Dilp-recruiting neurons (DRNs) \[[@pbio.3000721.ref044]\]. Whether local or systemic Dilp-2 activates PI3-kinase in the different brain cell types remains an open question. Once released, Dilp-2 could activate PI3-kinase in the different cell types in a simultaneous or sequential manner. Furthermore, Dilp-2 could stimulate synthesis and secretion of other Dilps and other factors that could promote autonomous or nonautonomous growth, either locally within the brain or systemically. Such factors may include Dilp-6, which is reported to be expressed in glia, and other Dilps that are expressed in neurosecretory neurons including the IPCs \[[@pbio.3000721.ref021],[@pbio.3000721.ref022],[@pbio.3000721.ref042],[@pbio.3000721.ref043],[@pbio.3000721.ref045]\].

In the brain, different cell types coordinate growth in response to dietary nutrients. Growth among different tissue types is also coordinated and relies on systemic factors, including the relaxin-like hormone, Dilp-8 \[[@pbio.3000721.ref046]--[@pbio.3000721.ref048]\]. For example, in response to tissue damage, Dilp-8 is expressed and secreted systemically, inducing developmental arrest and allowing time for tissue damage to self-repair. Once repair is complete, Dilp-8 levels decrease, development resumes, and adults emerge with appropriately sized and proportioned appendages \[[@pbio.3000721.ref046]--[@pbio.3000721.ref050]\]. Systemic growth is also regulated by 20-hydroxyecdysone, an ecdysteroid hormone that promotes growth globally and couples increases in cell and tissue size with developmental progression \[[@pbio.3000721.ref002],[@pbio.3000721.ref005],[@pbio.3000721.ref006]\]. Dietary nutrient conditions play a key role in both ecdysone production and developmental timing, as PI3-kinase regulates growth of the prothoracic gland that synthesizes and secretes ecdysone. Accumulated nutrient biomass is monitored by a \"critical weight\" check point in development: before critical weight, development is delayed if dietary nutrients are limited, but once animals reach \"critical weight,\" commitment to metamorphosis commences without delay regardless of dietary nutrients \[[@pbio.3000721.ref001]--[@pbio.3000721.ref006]\]. It will be important to determine whether coordinated cell growth occurs during tissue repair in periods of limited nutrient availability, and whether coordinated cell growth continues after \"critical weight\" is reached.

In mammals, cell growth decisions in response to nutrient availability are regulated by PI3-kinase and TOR-kinase signaling as well. However, how growth decisions are made and whether they are coordinated in response to dietary nutrients among stem cells within their local microenvironments is not well understood. Adult mammals, unlike flies, maintain a population of proliferative neural stem cells in the brain, some of which reside within rosette-like structures located along the walls of the lateral ventricle \[[@pbio.3000721.ref051]--[@pbio.3000721.ref052]\]. Multiciliated ependymal cells form the rosette with the stem cell and its primary cilium at the center \[[@pbio.3000721.ref053]\]. Both ependymal cells and stem cells receive signals through their cilia, which project into the ventricles filled with cerebral spinal fluid (CSF). The choroid plexus produces CSF and with it, a host of factors, including insulin-like growth factor (IGF) \[[@pbio.3000721.ref054]\]. Whether IGF regulates levels of PI3-kinase signaling in neural stem cells within their niche remains unclear, but loss of the rosette-like pinwheels correlates with decreased adult neurogenesis and premature progenitor differentiation \[[@pbio.3000721.ref053]\]. In the future, it will be interesting to determine whether dietary nutrients regulate choroid plexus IGF levels and how stem cells and their niche respond to IGF during homeostasis and aging.

Materials and methods {#sec011}
=====================

*Drosophila* stocks {#sec012}
-------------------

Genotypes of fly stocks used in this study and their source are listed in [S2](#pbio.3000721.s007){ref-type="supplementary-material"} and [S3](#pbio.3000721.s008){ref-type="supplementary-material"} Tables.

*Drosophila* maintenance and feeding methods {#sec013}
--------------------------------------------

Larvae were collected immediately after hatching and placed on either Bloomington fly food diet or in a sucrose-only solution. Freshly hatched larvae were maintained at 25°C on a 12-hour light/dark cycle for defined periods of time. Fly food or sucrose solution were supplemented with 0.1 mM EdU, and EdU incorporation was detected using commercially available Click-iT EdU Proliferation Kits for Imaging (Thermo Fisher Scientific, Waltham, MA, USA) as described previously \[[@pbio.3000721.ref026]\].

Immunofluorescence, dextran injections, and confocal imaging {#sec014}
------------------------------------------------------------

Larval brains were fixed and stained as previously described \[[@pbio.3000721.ref026]\]. In brief, early staged larval brains were dissected and fixed in 4% EM grade formaldehyde in PEM (Pipes, EGTA, magnesium chloride) buffer with 0.1% Triton-X for 20 mins. Tissues were washed in 1× PBT with 0.1% Triton-100 and blocked overnight at 4°C in 1X PBT with 10% normal goat serum. Primary antibodies used in this study include chicken anti-GFP (1:500; Abcam, Cambridge, MA, USA), rat anti-Dpn (1:100; Abcam), rabbit anti-Scribble (1:1,000), mouse anti-Repo (1:5; DSHB, 8D12). Primary antibodies were detected using Alexa Fluor-conjugated secondary antibodies. For dextran dye experiments, 10-kDa dextran conjugated to Alexa Fluor 647 was injected into L3 brains maintained in culture using micromanipulators. Brains were then fixed and stained as described above. Brains were imaged using a Leica SP8 laser scanning confocal microscope (Leica, Wetzlar, Germany) equipped with a 63×, 1.4 NA oil-immersion objective. For glia and trachea surface measurements, Z stacks were acquired at 0.5-μm steps using same confocal settings. All other confocal data were collected at 1.0-μm steps. Images were processed using the Imaris and Fiji software packages.

Cell counts and quantification of glia and tracheal membrane surface area {#sec015}
-------------------------------------------------------------------------

For neuroblast EdU quantification, the number of EdU-positive, Dpn-positive neuroblasts were counted using the "cell counter" plugin in Fiji and divided by the total number of Dpn-positive neuroblasts. For quantification of glia, the total number of Repo-positive nuclei were counted in each brain hemisphere and cortex, SPG, and neuropil glia distinguished based on their location and morphology. Neuroblast diameter was calculated based on the average length of 2 perpendicular lines drawn through center of the neuroblast at its widest point. To quantify glial and trachea surface area, GFP-expressing membranes were segmented and analyzed using the *Surface* module in Imaris 9.0.2 (Bitplane). Imaris Surface generates a volumetric surface object based on fluorescence intensity and creates a 3D surface mesh based on voxel intensity. After segmentation, a mask was generated and confirmed by manual visual inspection using Imaris slice mode. All confocal images used for surface area measurements were acquired using the same settings. For measurement of percentages of neuroblast membrane with glia contact, we used a Fiji plugin as described previously \[[@pbio.3000721.ref055]\]. Brains were mounted with their dorsal side closest to coverslip, and all non-MB neuroblasts within 30 microns of the coverslip were assayed.

Whole-brain Dilp-2 and Dilp-6 measurements {#sec016}
------------------------------------------

The CNS was dissected at 72 hours after larval hatching and lysed by sonication in extraction buffer (1× PBS with protease inhibitor). Lysed samples were cleared by centrifugation and dual-epitope tagged Dilp2 (Dilp2-HF) or Dilp6 (Dilp6-HF) was measured by ELISA \[[@pbio.3000721.ref056]\]. Protein concentration for normalization was measured using a bicinchoninic assay (BCA) (Pierce, Thermo Fisher Scientific). To convert molar concentrations to pg Dilp/mg protein, we used a molecular weight of 7,828.86 for mature Dilp2^HF^ protein (A-chain and B-chain with HA and FLAG tags) and 10,303.62 for mature Dilp6^HF^ protein (A-chain, C-peptide, and B-chain with HA and FLAG tags).

Quantitative RT-PCR {#sec017}
-------------------

Total RNA was extracted from the 24-hour--fed larval CNS. For each experimental sample, 40 brains were pooled in TRIzol, and isolated RNA was reverse transcribed into cDNA using SuperScript IV First-Strand Synthesis System kit (Thermo Fisher Scientific). Quantitative PCR was performed using the iQ SYBR Green Supermix system (Bio-Rad, Hercules, CA, USA). *Gapdh1* expression was used as a control. Relative *dilp2* and *dilp6* mRNA levels for each sample were calculated using the 2-ΔΔCt method after normalizing to *Gapdh1* expression. The following primers were used: *dilp6* \[[@pbio.3000721.ref045]\], *Gapdh1* \[[@pbio.3000721.ref022]\], *dilp2* forward: ACGAGGTGCTGAGTATGGTGTGCG, and *dilp2* reverse: CACTTCGCAGCGGTTCCGATATCG.

Statistical analysis {#sec018}
--------------------

Student *t* tests and one-way ANOVAs were performed using Prism 8. For box plots, the boundary of the box closest to zero indicates the 25th percentile, a line within the box marks the median, and the boundary of the box farthest from zero indicates the 75th percentile. Whiskers (error bars) above and below the box indicate the maximum and minimum, respectively. The data in plots and the text are presented as means ± SEM.

Supporting information {#sec019}
======================

###### Glia and trachea endoreplicate in response to animal feeding.

\(A\) Larval brain cartoon with red box indicating the brain region imaged in [Fig 1](#pbio.3000721.g001){ref-type="fig"} and all subsequent Figs. (B--E) Single confocal Z images of non-MB and MB NBs. Top and bottom left panels are single-channel grayscale images, with colored overlay in the bottom right. Molecular markers are denoted within panels and white brackets indicate NBs in this and all figures. (F) Box and whisker plots of NB diameter of EdU-negative (black) and EdU-positive (orange) NBs. The number of NBs analyzed is indicated below plots. Student two-tailed *t* test, \*\*\**p* \< 0.001. (G) Fold changes in brain volume per hemisphere in response to animal feeding (see [Materials and Methods](#sec011){ref-type="sec"}). Column numbers indicate number of brain hemispheres scored. Values are normalized to 0-hour--fed animals. (H) Single Z-plane of a brain hemisphere. Left and middle panels are color overlays of a control brain after feeding. High-magnification images of 2 Repo-positive glia are shown to the right, one EdU-positive and one EdU-negative (white boxes). (I) Quantification of EdU-positive glial cells per brain lobe in response to feeding. (J) Number of Repo-positive glial cells per brain hemisphere before and after animal feeding. (K) Single Z image of a brain hemisphere from a *dupRNAi* knockdown animal. Left and middle panels are color overlays with high magnification of 2 Repo-positive glia shown to the right (white boxes). (L) Quantification of glia number in *dupRNAi* knockdown animals compared to control. (M) Single Z image of a brain hemisphere. Left and middle panels are color overlays of control brain after feeding. A high-magnification image of a tracheal nucleus is shown to the right (white boxes). (N) Quantification of EdU in trachea from animals fed standard food or sucrose. (G,I) One-way ANOVA with Tukey post hoc analysis and (F,J,L,N) Student two-tailed *t* test, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. *dupRNAi*, *double-parked* RNA interference; EdU, 5-ethynyl-2′-deoxyuridine; MB, mushroom body; NB, neuroblast; Repo, reversed polarity.

(TIF)

###### 

Click here for additional data file.

###### PI3-kinase--dependent growth regulation in the developing brain.

\(A\) Maximum intensity projection of a single brain hemisphere labeled with EdU and quantification of NB size from indicated genotypes (B). (C,M) Glial and (E,H,I,K) tracheal morphology with quantification of glial surface area (D,N) and tracheal surface area from indicated genotypes (F,J,L). Top panels are colored overlays, with bottom panels showing single-channel grayscale images (A), single channel and mask (C,M), or rendered maximum intensity projection with segmentation of trachea (E,H,I,K). Molecular markers are denoted within panels. (G) Quantification of glial number. (B,D,F,J,L,N) Student two-tailed *t* test, \**p* \< 0.05, \*\**p* \< 0.01,\*\*\**p* \< 0.001, error bars, SEM. (G) One-way ANOVA with Tukey post hoc analysis. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. EdU, 5-ethynyl-2′-deoxyuridine; NB, neuroblast; PI3-kinase, phosphoinositide 3-kinase.

(TIF)

###### 

Click here for additional data file.

###### Glial identify based on location and GAL4 expression.

\(A\) Single Z image of a segmented brain hemisphere with glia subtypes and corresponding GAL4 lines. (B) Total number of glia subtypes before and after animal feeding. Glia type was identified based on location. Error bars, SEM. Black circles indicate single brain hemispheres. (C and E) Left panels, colored overlays of a single Z-plane from a brain hemisphere of the indicated genotype, with grayscale images on the right. Molecular markers are denoted within panels. Quantification of glial populations are shown in D and F. Red columns depict mean of histoneRFP-expressing glia, and black columns depict mean of glia identified based on position. Whites boxes indicate RFP-expressing cortex glia in (C) and SPG in (E). Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. RFP, red fluorescent protein; SPG, subperineurial glia.

(TIF)

###### 

Click here for additional data file.

###### Delayed NB reactivation and cortex glial growth in *dilp2* mutants is not due to delays in developmental timing.

\(A\) Box plots of NB diameter of EdU-negative (black) versus EdU-positive (orange) NBs. Column numbers indicate number of NBs analyzed. (B,C) Quantification of EdU-positive neuroblasts (B) and cortex glial membrane surface (C) area after 48 hours of feeding of indicated genotypes. (D,E) Mouth hook morphology of control and *dilp2* mutants at indicated times. (A--C) Student two-tailed *t* test, \*\**p* \< 0.01. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. Dilp, *Drosophila* insulin-like peptide; EdU, 5-ethynyl-2′-deoxyuridine; NB, neuroblast.

(TIF)

###### 

Click here for additional data file.

###### NB EdU incorporation in *dilp2*, *dilp6* double mutants.

(A,B) EdU-positive NBs after 24 hours of feeding in *dilp2*, *dilp6* double mutants. (A) Maximum intensity projection of a brain hemisphere. Top panel is a colored overlay (red, Dpn; green, EdU), and the bottom panel is a single-channel grayscale image (EdU) below with quantification in (B). Brain hemispheres are outlined, and the dotted vertical line indicates the midline. (B) One-way ANOVA with Tukey post hoc analysis. \*\*\**p* \< 0.001. Genotypes of panels listed in [S2 Table](#pbio.3000721.s007){ref-type="supplementary-material"} and data listed in [S1 Data](#pbio.3000721.s009){ref-type="supplementary-material"}. Dilp, *Drosophila* insulin-like peptide; Dpn, Deadpan; EdU, 5-ethynyl-2′-deoxyuridine; NB, neuroblast.

(TIF)

###### 

Click here for additional data file.

###### Classification of glial GAL4 expression in the larval brain after 24 hours of feeding.

(DOCX)

###### 

Click here for additional data file.

###### Genotypes listed by figure panel.

(DOCX)

###### 

Click here for additional data file.

###### *Drosophila* stock list and source.

(DOCX)

###### 

Click here for additional data file.

###### Excel spreadsheet with data listed for all main and supplementary figures.

(XLSX)

###### 

Click here for additional data file.

We thank Andrea Brand, Marc Freeman and the Bloomington and Kyoto stock centers for fly stocks and reagents. We especially thank Susan Doyle, Chhavi Sood, and Nahid Ausrafuggaman for help in tissue dissections. We thank Chris Doe, Susan Doyle, and Karsten Siller for providing comments on the manuscript.

Akt/PKB

:   Protein Kinase B

ALH

:   after larval hatching

BCA

:   bicinchoninic assay

BBB

:   blood--brain barrier

btl

:   *breathless*

CNS

:   central nervous system

CSF

:   cerebral spinal fluid

Dilp

:   *Drosophila* insulin-like peptide

Dpn

:   Deadpan

dp60

:   *Drosophila protein 60*

DRN

:   Dilp-recruiting neuron

dupRNAi

:   *double-parked* RNA interference

EdU

:   5-ethynyl-2′-deoxyuridine

FDS

:   fat-body--derived signal

Foxo

:   forkhead box, subgroup O

Gapdh1

:   Glyceraldehyde-3-phosphate dehydrogenase 1

GFP

:   green fluorescent protein

IGF

:   insulin-like growth factor

InR

:   insulin-like tyrosine kinase receptor

IPC

:   insulin-producing cell

MB

:   mushroom body

mCD8

:   membrane-targeted CD8 antigen

pcna

:   proliferating cell nuclear antigen

PDGFR

:   Platelet-derived growth factor receptor

PEM

:   Pipes, EGTA, magnesium chloride

PIP~3~

:   phosphatidylinositol (3,4,5)-triphosphate

PI3-kinase

:   phosphoinositide 3-kinase

Pten

:   phosphatase and tensin homolog

PVR

:   PDGF- and VEGF-receptor related

raptorRNAi

:   *raptor* RNA interference

repo

:   *reversed polarity*

RFP

:   red fluorescent protein

Scrib

:   Scribble

SPG

:   subperineurial glia

TOR

:   target of rapamycin

UAS

:   upstream activating sequence

VNC

:   ventral nerve cord

wor

:   *worniu*
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2 Oct 2019

Dear Dr Siegrist,

Thank you for submitting your manuscript entitled \"Dilp-2 mediated PI3-kinase activation coordinates reactivation of quiescent neuroblasts with growth of their glial stem cell niche\" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff \[as well as by an academic editor with relevant expertise\] and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the \'Submissions Needing Revisions\' folder on your homepage. Please click \'Revise Submission\' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by Oct 04 2019 11:59PM.

Login to Editorial Manager here: <https://www.editorialmanager.com/pbiology>

During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit <http://journals.plos.org/plosbiology/s/preprints> for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Feel free to email us at <plosbiology@plos.org> if you have any queries relating to your submission.

Kind regards,

Di Jiang,

Associate Editor

PLOS Biology

10.1371/journal.pbio.3000721.r002

Decision Letter 1

Jiang

Di

Senior Editor

© 2020 Di Jiang

2020

Di Jiang

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

5 Nov 2019

Dear Dr Siegrist,

Thank you very much for submitting your manuscript \"Dilp-2 mediated PI3-kinase activation coordinates reactivation of quiescent neuroblasts with growth of their glial stem cell niche\" for consideration as a Research Article at PLOS Biology. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by four independent reviewers.

In light of the reviews (below), we will not be able to accept the current version of the manuscript, but we would welcome resubmission of a much-revised version that takes into account the reviewers\' comments. You will need to re-write the paper including its Abstract, Introduction, Results, and Discussion to inform the reader clearly what are the novel results and what aren\'t. You should emphasise the novel results and expand them while moving the confirmation experiments to supplementary information to ensure the distinction. We will want to see all experiments suggested by reviewer 3. You will also need to address several points raised by reviewer 4 by more careful analyses of the experiments you have already done and more discussion. You should also respond to this reviewer\'s points related to the sucrose effect through better introduction and contextualisation of previous studies on neuroblast reactivation in response to dietary amino acids and/or additional experiments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers\' comments. Your revised manuscript is also likely to be sent for further evaluation by the reviewers.

Your revisions should address the specific points made by each reviewer. Please submit a file detailing your responses to the editorial requests and a point-by-point response to all of the reviewers\' comments that indicates the changes you have made to the manuscript. In addition to a clean copy of the manuscript, please upload a \'track-changes\' version of your manuscript that specifies the edits made. This should be uploaded as a \"Related\" file type. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

Before you revise your manuscript, please review the following PLOS policy and formatting requirements checklist PDF: <http://journals.plos.org/plosbiology/s/file?id=9411/plos-biology-formatting-checklist.pdf>. It is helpful if you format your revision according to our requirements - should your paper subsequently be accepted, this will save time at the acceptance stage.

Please note that as a condition of publication PLOS\' data policy (<http://journals.plos.org/plosbiology/s/data-availability>) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: <http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5>.

For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article\'s figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: <https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements>.

Upon resubmission, the editors will assess your revision and if the editors and Academic Editor feel that the revised manuscript remains appropriate for the journal, we will send the manuscript for re-review. We aim to consult the same Academic Editor and reviewers for revised manuscripts but may consult others if needed.

We expect to receive your revised manuscript within two months. Please email us (<plosbiology@plos.org>) to discuss this if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not wish to submit a revision and instead wish to pursue publication elsewhere, so that we may end consideration of the manuscript at PLOS Biology.

When you are ready to submit a revised version of your manuscript, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' where you will find your submission record.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don\'t hesitate to contact us if you have any questions or comments.

Sincerely,

Di Jiang

PLOS Biology

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer remarks:

Reviewer \#1: Review of "Dilp-2 mediated PI3-kinase activation coordinates reactivation of quiescent neuroblasts with growth of their glial stem cell niche"

Author summary:

Here, we report that Drosophila neural stem cells, known as neuroblasts, reactivate from developmental quiescence in a dietary nutrient-dependent manner. Neuroblast reactivation requires non-cell autonomous activation of PI3-kinase signaling from cortex glia and tracheal processes, both of which are closely associated with neuroblasts. Furthermore, PI3-kinase activation in neuroblasts is required non-cell autonomously for glial membrane expansion and robust neuroblast-glial contact. Finally, PI3-kinase is required cell autonomously for nutrient dependent growth of neuroblasts, glia, and trachea. Of the seven Drosophila insulin-like peptides (Dilps), we find that Dilp-2 is required for PI3-kinase activation and growth coordination between neuroblasts and glia. Dilp-2 induces cortex glia to initiate membrane growth and make first contact with quiescent neuroblasts. After contact, neuroblasts increase in size and reenter S-phase. Once reactivated from quiescence, neuroblasts promote growth of cortex glia which in turn form a selective membrane barrier around neuroblasts and their newborn progeny.

I really liked this paper. The results are novel, particularly the role of trachea in signaling to neuroblasts. The results are well-supported by the figures and statistics provided. The figures are clear and highlight the relevant phenotypes in a convincing manner.

Major comments

None

Minor comments

1\. Consider splitting the quite long results section "Nutrient-dependent growth of neuroblasts, glia, and trachea requires cell autonomous and cell non-autonomous activation of PI3-kinase" into two sections, one for cell autonomous data and one for cell non-autonomous data. This is optional at author discretion.

2\. If the authors have data on knockdown of PI3K in both glia and trachea they should include it. These two cell types are likely functioning semi-redundantly in signaling to neuroblasts.

3\. Several glial subtype Gal4 lines characterized on page 8; why was the well-known astrocyte-specific alrm-Gal4 line excluded? Just curious.

4\. Page 8 second line from bottom. I think "compared" should be "comparable"

5\. Page 10 second paragraph says "growth coordination between cortex glia and neuroblasts is Dilp-2 dependent" -- which raises the question of what is the effect of creating a mismatch in growth coordination where neuroblasts and glia grow differently? Is there an effect on viability? Brain development?

Reviewer \#2: Xin Yuan et al. described a role of Dilp-2 mediated PI3-kinase activation in coordinating reactivation of quiescent neuroblasts with growth of glial niche. They reported that nutrient-dependent growth of neuroblasts, glia and trachea requires cell autonomous and cell non-autonomous activation of PI3-kinase. They went on to show that several different subtypes of glia, including cortex glia, subperineural glia (SPG) and neuropil glia, require dietary nutrients and PI3-kinase activity for growth. The authors found that cortex glia are required to reactivate neuroblasts and that Dilp-2 regulates neuroblast reactivation, cortex glia membrane growth and Dilp-6 protein levels. Finally, they demonstrated that increases in neuroblast membrane with glia contact precede increases in neuroblast size, implying that cortex glia membrane contact triggers neuroblast growth and reactivation. Overall, they presented an impressive amount of data, some of which are very interesting.

Major concern

This manuscript significantly overlapped with data previously reported (Pauline Speder and Andrea Brand, Elife, January 2018) in the following conclusions. 1) Neuroblast reactivation induces remodelling of cortex glia; 2) Nutrition-induced activation of PI3K/Akt drives the cortex glia to expand their membrane processes; 3) Dilps are required for development of cortex glia. One major claim of the current manuscript is the role of cortex glia in neuroblast reactivation, which contradicts with the previous conclusion that cortex glia has little impact on neuroblast reactivation (Elife 2018). The relevant findings on development/remodelling of cortex glia associated with neuroblast reactivation reported on Elife 2018 was wrongly referred to as SPG glia in the introduction on page 3 of this manuscript. The authors are advised to remove duplicated data and to provide the reasons underlying these different conclusions on the role of cortex glia in neuroblast reactivation.

Reviewer \#3: In this paper Yuan and coworkers address how different cell types coordinate their growth in response to dietary nutrients. They use neuroblasts in the fly brain since these neural stem cells reactivate from quiescence in a nutrient dependent manner and are in close contact with other tissues in the niche (i.e. glia and trachea). The main claims of the paper are:

1\) that the coordinated growth between neuroblast and cortex glia is based on a bidirectional growth signaling between these two tissues.

2\) that dilp2 is required for neuroblast reactivation and cortex glia growth and hence the coordination of the two processes.

The idea in first claim is not completely novel. Speder and Brand. eLife 2018;7:e30413 have shown that cortex glia growth in the niche is nutrient dependent and that it requires autonomous activation of PI3K . They also acknowledge the existence of another signal regulating cortex glia growth and link it to neuroblast reactivation. Yuan et al. main contribution to claim 1 is to propose that this signal is Dilp2 dependent PI3K activation in the neuroblast. If besides this contribution, the authors consider that their results add more to this claim, this was not evident in the text and they might want to emphasize any points that add to Speder and Brand findings.

The second claim is novel and is actually reflected in the title of the manuscript. Sousa-Nunes et al. 2011, Chell and Brand 2010, have shown that Dilps are involved in neuroblast reactivation (dilp2, 3, 5, 6) with some being expressed in glia (dilp3, 6), this paper addresses which dilp is required to coordinate the reactivation of neuroblasts and the growth of cortex glia. Through loss of function analyses they propose that dilp2 mediates neuroblast reactivation and cortex glia growth. They carry out a detailed analysis showing that an increase in glia-neuroblast membrane contacts increase takes place prior to neuroblast reactivation.

These are interesting findings that would gain strength and benefit from additional experiments.

Revision of the following major points is essential prior to publication:

1\. The loss of function analysis of Dilps is done with null alleles generated though homologous recombination. It seems, based on the genotype provided, that they are analyzed in homozygous conditions. This has the risk of carrying additional 2nd site mutations in homozygosis. It would be reassuring to verify the Dilp2 results for neuroblast EdU incorporation and cortex glia growth with an additional allelic combination removing Dilp2 using two independent mutant chromosomes (dilp2/def or two dilp2 mutants from independent homologous recombination events).

2\. Dilp2 null mutant has been reported to have a developmental delay. A time line experiment analyzing reduction in EdU incorporation and cortex glia growth at later time points than 24hrs of feeding could distinguish whether the phenotypes observed are sustained in time or a consequence of the developmental delay.

3\. Cell type specific rescue experiments could identify the source of Dilp2, test sufficiency and specificity (i.e. would dilp6 overexpression rescue the dilp2 phenotype?).

While Sousa-Nunes et al. 2011, Chell and Brand 2010 are referenced in the manuscript, a better description of what is already known about Dilp involvement in neuroblast reactivation might help this manuscript to highlight their own contributions, and make it more accessible to non-specialists. The details of the methodology are sufficient to allow the experiments to be reproduced.

Minor points:

1\. In the second block of results "Nutrient dependent growth ..."

\- When levels of PI3-kinase activity were reduced in neuroblasts (worGAL4, UAS dp60), neuroblast EdU incorporation was reduced and neuroblast size reduced as previously reported (Figure 2B and S2A) → It would help if the reader were referred to compare S2A to Figure 1J for the Edu incorporation reduction

\- When levels of PI3-kinase activity were reduced in all glia (repoGAL4, UAS-dp60), EdU incorporation was essentially absent in glia and membrane surface area reduced (Figure 2C and S2B,C). → It would help if the reader were referred to compare S2B to Figure 1P for glia membrane surface area reduction. It is unclear how the information that S2C provides fits here

\- Reduction of PI3-kinase activity in trachea (btlGAL4, UAS-dp60), eliminated EdU incorporation and tracheal surface area and branching were reduced (Figure 2D and S2D). → It would help if the reader were referred to compare S2D to Figure 1V for tracheal phenotypes.

EdU experiments mentioned above are not shown for either glia or trachea, the way it is written makes the reader expect the data in the referred figures. It would be desirable to see these data in the supplementary figure.

\- Figure 2N, O: The Figure panels in do not match the figure legend.

2\. Discussion

\- PVF was meant to mean PVR? Please spell out acronym.

3\. Figure legend 6

\- (H) One-way ANOVA with Tukey's post hoc analysis and (K) Student's two-tailed t test → Is K supposed to be L?

4\. Figure 7

\- glia (repoGAL4,UAS-mCD8:GFP) at the top of panel A → does not match the mCD8:RFP labeling indicated in panel A or the genotype of these animals as specified in S5 table.

Reviewer \#4: The authors use a series of cell specific alterations of the PI3K pathway to define both autonomous and non-autonomous relationships between neuroblasts, glia, and trachea in regulating their growth. The paper is well written and the experiments are elegant. Overall, the findings of the manuscript provide new and detailed insights into the crosstalk between cells in the brain that are required for proper growth of the brain in response to nutrition. My specific comments can be found below.

To determine whether the gial have undergone endo-reduplication the authors could DAPI quantify their nuclei.

Do trachea undergo endo-reduplication?

It would be helpful at the end of the results section relevant to Figure 1 to summarize the specific changes that occur in response to feeding and their relative timing.

How does NB diameter in sucrose fed animals, compare to worGal4 UAS-dp60?

How does glial membrane surface area in sucrose fed animals, compare to repoGal4 UAS-dp60?

How does tracheal surface area in sucrose fed animals, compare to btlGal4 UAS-dp60?

Why do the authors think that glial membrane growth reduction is only modest after inactivation of the PI3 kinase pathway in NBs? Do they think there are other signals or do they think the expression of dp60 is not strong enough to inactivate the PI3 Kinase pathway?

Why do the authors think that NB incorporation of EdU is only modest after inactivation of the PI3 kinase pathway in trachea? Do they think there are other signals or do they think the expression of dp60 is not strong enough to inactivate the PI3 Kinase pathway?

What happens to NB size after inactivation of the PI3 kinase pathway in trachea?

A table that summarizes the outcome of the experiments described in Figure 2 would be helpful.

"Somewhat surprisingly, neuroblast EdU incorporation in dilp6 null mutants was not changed \..."

Why is this surprising?

Why is there an affect on NB incorporation of EdU in dilp1 and in dilp7 mutants? In other words, where would the authors put dilp1 and dilp7 relative to dilp2 mechanistically or at least genetically?

Can cell specific activation of the PI3 kinase pathway in one cell type rescue non-autonomously phenotypes seen in other cell types in animals mutant for dilps, or fed sucrose?

"Trachea allow for oxygen exchange, but are also important sources of cell signaling molecules, including EGF-R and FGF-R."

What are EGF-R and FGF-R? Do they mean the ligands or the receptors?

10.1371/journal.pbio.3000721.r003

Author response to Decision Letter 1

6 Mar 2020

###### 

Submitted filename: reviewer response 3 04 20.docx

###### 

Click here for additional data file.

10.1371/journal.pbio.3000721.r004

Decision Letter 2

Jiang

Di

Senior Editor

© 2020 Di Jiang

2020

Di Jiang

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

1 Apr 2020

Dear Dr Siegrist,

Thank you for submitting your revised Research Article entitled \"Dilp-2 mediated PI3-kinase activation coordinates reactivation of quiescent neuroblasts with growth of their glial stem cell niche\" for publication in PLOS Biology. I have now obtained advice from three of the four original reviewers and have discussed their comments with the Academic Editor.

Based on the evaluations, we\'re delighted to let you know that we\'re now editorially satisfied with your manuscript. However before we can formally accept your paper and consider it \"in press\", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can\'t proceed until these requirements are met, your swift response will help prevent delays to publication. Please also make sure to address the data and other policy-related requests noted at the end of this email.

\*Copyediting\*

Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

<https://journals.plos.org/plosbiology/s/supporting-information>

\*Published Peer Review History\*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

<https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/>

\*Early Version\*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

\*Protocols deposition\*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods>

\*Submitting Your Revision\*

To submit your revision, please go to <https://www.editorialmanager.com/pbiology/> and log in as an Author. Click the link labelled \'Submissions Needing Revision\' to find your submission record. Your revised submission must include a cover letter, a Response to Reviewers file that provides a detailed response to the reviewers\' comments (if applicable), and a track-changes file indicating any changes that you have made to the manuscript.

Please do not hesitate to contact me should you have any questions.

Sincerely,

Di Jiang, PhD

Associate Editor

PLOS Biology

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: <http://journals.plos.org/plosbiology/s/data-availability>. For more information, please also see this editorial: <http://dx.doi.org/10.1371/journal.pbio.1001797>

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1\) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as \'Supporting Information\' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2\) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figures 1FLR, 2EHIK, 3DH, 4DEHIL, 5AGJ, 6CF-K, 7CDK, S1FGIJLN, S2BDFGJLN, S3ADF. NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

BLOT AND GEL REPORTING REQUIREMENTS:

For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article\'s figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: <https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements>

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

Reviewer remarks:

Reviewer \#1: The authors have addressed my points satisfactorily. I liked the first version quite a bit, and it is even better noe. In addition, I appreciate the effort taken by reviewers 2-4, and I feel the authors have addressed the vast majority of their comments too, which makes this a much improved paper. I am strongly in favor of acceptance and rapid publication.

Reviewer \#3: The authors have satisfactorily addressed all my concerns, both by rewriting sections of the manuscript and performing the experiments suggested. These changes have improved the manuscript by better highlighting and differentiating their work from previously published articles.

Reviewer \#4: The authors have adequately addressed my comments from the first review. I recommend publication.
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Dear Dr Siegrist,

On behalf of my colleagues and the Academic Editor, Catarina C Homem, I am pleased to inform you that we will be delighted to publish your Research Article in PLOS Biology.

The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you\'ll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication.

Early Version

The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with <biologypress@plos.org>. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit <http://www.plos.org/about/media-inquiries/embargo-policy/>.

Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process.
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Alice Musson

Publishing Editor,
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Di Jiang,

Associate Editor
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